Showing results (1701-1710 of 2,725) with videos related to
Sort By:
Pageof 273
The New Microbiologica|April 13, 2006
Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004)Maria Cristina Medici, Maria Cristina Arcangeletti, Giovanni A Rossi, et al.Anais Da Academia Brasileira De Ciencias|June 3, 2016
Metabolic responses of channel catfish (Ictalurus punctatus) exposed to phenol and post-exposure recoveryFernanda D Moraes, Priscila A Rossi, Juliana S L Figueiredo, et al.Veterinary Microbiology|August 1, 2017
A haplotype at intron 8 of PTPRT gene is associated with resistance to Brucella infection in Argentinian creole goatsUrsula A Rossi, Flavia C Hasenauer, Maria E Caffaro, et al.Journal of Shoulder and Elbow Surgery|November 6, 2020
Is sarcopenia a risk factor for rotator cuff tears?Nicolás A Atala, Santiago L Bongiovanni, Ana M Galich, et al.Biomaterials|July 31, 2012
Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cellsRafi Chapanian, Iren Constantinescu, Nicholas A A Rossi, et al.Journal of Affective Disorders|August 26, 1998
Effect of aging and sex on the [3H]-paroxetine binding to human plateletsD Marazziti, A Rossi, L Palego, et al.Diabetes Research and Clinical Practice|January 29, 2026
Insights for personalized choice of a hybrid closed-loop system: an expert opinionS Di Molfetta, F Boscari, A Rossi, et al.Journal of Molecular and Cellular Cardiology|July 1, 1997
Energy metabolism in normal and hypertrophied right ventricle of the ferret heartE Do, S Baudet, M Verdys, et al.The American Journal of Tropical Medicine and Hygiene|October 29, 2009
Micro-positron emission tomography in the evaluation of Trypanosoma cruzi-induced heart disease: Comparison with other modalitiesCibele M Prado, Eugene J Fine, Wade Koba, et al.British Journal of Pharmacology|April 22, 2011
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivoC Greiner, C Hörnig, A Rossi, et al.Pageof 273